blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3609867

EP3609867 - CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  12.04.2024
Database last updated on 03.06.2024
FormerGrant of patent is intended
Status updated on  12.12.2023
FormerExamination is in progress
Status updated on  21.11.2023
FormerGrant of patent is intended
Status updated on  13.07.2023
FormerExamination is in progress
Status updated on  26.11.2021
FormerRequest for examination was made
Status updated on  17.01.2020
FormerThe international publication has been made
Status updated on  20.10.2018
Most recent event   Tooltip12.04.2024(Expected) grantpublished on 15.05.2024  [2024/20]
Applicant(s)For all designated states
GSNO Therapeutics, Inc.
191 SE Vic King Rd.
Shelton, WA 98584 / US
[2023/32]
Former [2020/08]For all designated states
Saje Pharma, LLC
1101 E. 33rd Street
Third Floor
Baltimore, Maryland 21218 / US
Inventor(s)01 / PARIZA, Richard J.
c/o SAJE Pharma LLC
1101 E. 33rd Street
Third Floor
Baltimore, Maryland 21218 / US
02 / BRADLEY, Matthews O.
c/o SAJE Pharma, LLC
164 Saddleback Trail
Kalispell, MT 59901 / US
 [2020/19]
Former [2020/08]01 / PARIZA, Richard J.
c/o SAJE Pharma LLC
1101 E. 33rd Street
Third Floor
Baltimore, Maryland 21218 / US
02 / BRADLEY, Matthews O.
c/o SAJE Pharma LLC
1101 E. 33rd Street
Third Floor
Baltimore, Maryland 21218 / US
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2024/20]
Former [2020/08]Wallace, Sheila Jane
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
Application number, filing date18783804.011.04.2018
[2020/08]
WO2018US27170
Priority number, dateUS201762484128P11.04.2017         Original published format: US 201762484128 P
US201762565044P28.09.2017         Original published format: US 201762565044 P
[2020/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018191418
Date:18.10.2018
Language:EN
[2018/42]
Type: A1 Application with search report 
No.:EP3609867
Date:19.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2018 takes the place of the publication of the European patent application.
[2020/08]
Type: B1 Patent specification 
No.:EP3609867
Date:15.05.2024
Language:EN
[2024/20]
Search report(s)International search report - published on:US18.10.2018
(Supplementary) European search report - dispatched on:EP28.10.2020
ClassificationIPC:C07D209/82, C07D209/88, C07D209/86, C07D401/04, C07D403/06, C07D409/14, C07D413/12, C07D417/12, C07D403/04, A61K31/403, A61P29/00, A61K31/4178
[2023/25]
CPC:
C07D403/04 (EP,US); C07D409/14 (EP,US); A61P29/00 (EP);
C07D209/86 (EP,US); C07D209/88 (EP,US); C07D401/04 (EP,US);
C07D403/06 (EP,US); C07D413/12 (EP,US); C07D417/12 (EP,US) (-)
Former IPC [2020/48]C07D209/82, C07D209/88, C07D209/86, C07D401/04, C07D403/06, C07D409/14, C07D413/12, C07D417/12
Former IPC [2020/08]C07D209/82, C07D209/88
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/08]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:CARBAZOLVERBINDUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON[2020/08]
English:CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF[2020/08]
French:COMPOSÉS CARBAZOLE ET LEURS PROCÉDÉS D'UTILISATION[2020/08]
Entry into regional phase30.10.2019National basic fee paid 
30.10.2019Search fee paid 
30.10.2019Designation fee(s) paid 
30.10.2019Examination fee paid 
Examination procedure30.10.2019Examination requested  [2020/08]
27.05.2021Amendment by applicant (claims and/or description)
25.11.2021Despatch of a communication from the examining division (Time limit: M04)
31.03.2022Reply to a communication from the examining division
15.09.2022Despatch of a communication from the examining division (Time limit: M04)
24.01.2023Reply to a communication from the examining division
14.07.2023Communication of intention to grant the patent
21.11.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.12.2023Communication of intention to grant the patent
09.04.2024Fee for grant paid
09.04.2024Fee for publishing/printing paid
09.04.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
31.03.2020Renewal fee patent year 03
15.04.2021Renewal fee patent year 04
02.03.2022Renewal fee patent year 05
27.02.2023Renewal fee patent year 06
26.02.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]US3956295  (BIERE HELMUT, et al) [X] 1-4,6,8,9,13,15 * claims 4-49; columns 7-8 * [I] 12;
 [X]US2005031899  (NOMURA RYOJI [JP], et al) [X] 1-3,5,8,11 * compound (23) in p. 10 *;
 [X]WO2008100867  (INTERMUNE INC [US], et al) [X] 1-4,7,8 * compounds 7 and 8 in p. 145 *;
 [X]EP2119704  (ASTELLAS PHARMA INC [JP]) [X] 1-4,8,9,13,15 * compounds 58-73 in Table 2 in p. 23, 129-144 in Table 6, p. 25, compounds 249, 243, 245, 247, 248, 275, 276, 279, 281, 281, 287-289, 295, 298-300, 302, 313, 314, 316, 354, 350 *;
 [XI]US2012039804  (DIAZ PHILIPPE [US], et al) [X] 1-4,8,9,13,15 * compounds 30-32, 43, claim 4 (2nd and 7th to last compounds) * [I] 12;
 [A]WO2012170371  (N30 PHARMACEUTICALS LLC [US], et al) [A] 1-15 * the whole document *;
 [X]  - ANGELO D. FAVIA ET AL, "Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor", JOURNAL OF MEDICINAL CHEMISTRY, US, (20121025), vol. 55, no. 20, doi:10.1021/jm3011146, ISSN 0022-2623, pages 8807 - 8826, XP055740566 [X] 1-4,6,8,9,13,15 * compounds 1-3, 4a-4b, 6a-6g, 10a-10g, 12, 15a-15k, p. 8807 *

DOI:   http://dx.doi.org/10.1021/jm3011146
 [X]  - ZHOU H P ET AL, "A new ligand for the formation of a 3D structure by C-H...O, O-H...O hydrogen-bonds and @p-@p interactions", JOURNAL OF MOLECULAR STRUCTURE, ELSEVIER, AMSTERDAM, NL, vol. 892, no. 1-3, doi:10.1016/J.MOLSTRUC.2008.05.042, ISSN 0022-2860, (20081215), pages 316 - 319, (20080607), XP025658905 [X] 1-3,5,8,11 * abstract *

DOI:   http://dx.doi.org/10.1016/j.molstruc.2008.05.042
 [X]  - ZHANG SHU-FANG ET AL, "Syntheses, structures, luminescent and gas adsorption properties of five new interpenetrated, 2D and 3D metal-organic frameworks based on a semi-rigid bis(imidazole)-carbazole ligand", POLYHEDRON, (20151019), vol. 102, doi:10.1016/J.POLY.2015.08.040, ISSN 0277-5387, pages 401 - 409, XP029341244 [X] 1-3,5,8,10,11 * compound L in p. 402 *

DOI:   http://dx.doi.org/10.1016/j.poly.2015.08.040
 [A]  - XICHENG SUN ET AL, "Structureactivity relationship of pyrrole based-nitrosoglutathione reductase inhibitors: Carboxamide modification", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM,NL, vol. 22, no. 6, doi:10.1016/J.BMCL.2012.01.047, ISSN 0960-894X, (20120113), pages 2338 - 2342, (20120202), XP028402869 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2012.01.047
International search[Y]US2003229073  (BOOTH RICHARD JOHN [US], et al) [Y] 1, 13, 14/1, 14/13 * ; paragraphs [0007], [0011], [0025] *;
 [Y]US2009170906  (GUDMUNDSSON KRISTJAN [US], et al) [Y] 1, 13, 14/1, 14/13* ; paragraph [0007] *
ExaminationWO2012011642
by applicantUS3956295
 US4107288
 US5145684
 US2005031899
 WO2008100867
 EP2119704
 WO2012011642
 US2012039804
 WO2012170371
    - FAVIA, A. D. et al., Journal of Medicinal Chemistry, (20121025), vol. 55, no. 20, pages 8807 - 8826
    - ZHOU, H. P. et al., Journal of Molecular Structure, (20081215), vol. 892, pages 316 - 319
    - ZHANG, S.-F. et al., Polyhedron, (20051019), vol. 102, pages 401 - 409
    - XICHENG S. et al., Bioorganic & Medicinal Chemistry Letters, (20120113), vol. 22, no. 6, pages 2338 - 2342
    - Fieser and Fieser's Reagents for Organic Synthesis, John Wiley, and Sons, (19910000), vol. 1
    - Larock's Comprehensive Organic Transformations, Elsevier Science Publishers, (19890000), vol. 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.